| Advertisement |
Generic
Social Networks And Brand Advertising
By Mike Sachoff - Tue, 09/04/2007 - 5:17pm.
U.S. social networking sites may generate revenue that could reach $1 billion in 2007, and increase from $400 million in 2006, according to IDC's "Social Networking Services in the US-Popular, Yes, But how To Monetize Them?" report.
Google Losing Fight For Its Name
By WebProNews Staff - Wed, 05/02/2007 - 10:59am.
The search advertising company has been fighting against the usage of its name as a verb ever since Merriam-Webster put 'google' in the dictionary. It's a battle they are not going to win.
Does Google Police Online Pharmacies Enough?
By Jason Lee Miller - Fri, 04/27/2007 - 12:30pm.
Recent deaths associated with drugs bought at online pharmacies have brought the issue front and center for many Americans. It's still unclear as to whose responsibility it is to police them, but the strongest critics are pointing fingers at search engines and comparison-shopping sites.
Will Domain Names Become Less Relevant?
By Aaron Wall - Tue, 04/03/2007 - 9:07am.
Currently domain names carry significant weight in Google's relevancy algorithms if they match the search query, but that is a signal destined to lose value.
Fake Generic Viagra Site Using Google Name
By Nathan Weinberg - Thu, 06/08/2006 - 1:54pm.
The Register writes about a fake pharmacy, which purports to sell pills that don't exist, and uses the Google name to try to appear legitimate.
Why Experts Reject Generic Memetrackers
By Ken Yarmosh - Fri, 03/17/2006 - 9:31am.
Last week Scoble explained why he was unsubscribing from Memeorandum. More recently he wrote...
Why Experts are Rejecting Generic Memetrackers
By Ken Yarmosh - Thu, 03/16/2006 - 9:55am.
Last week Scoble explained why he was unsubscribing from Memeorandum.
Teva/Ranbaxy Required To Withdraw Generic Quinapril
By WebProNews - Wed, 03/30/2005 - 11:36am.
Pfizer has obtained a preliminary injunction halting sales of a generic quinapril product marketed by Teva Pharmaceuticals USA, Ranbaxy Pharmaceuticals, and Ranbaxy Laboratories.
Novartis Buys Up Generic Drug Makers
By WebProNews - Tue, 02/22/2005 - 1:19pm.
Novartis is buying generic-drug makers Eon Labs and Hexal for a total of $8.3 billion in cash.
Novartis Buys 2 Big Generic Drug Companies
By WebProNews - Mon, 02/21/2005 - 10:53am.
Novartis is acquiring two leading generic drug companies that will be integrated into the company's Sandoz division.
Latest News on: WebProWire.com
Nintendo's Wii sees patent... BloggingStocksBebo appoints exec to handle... CNET News.com
Making sense of a VMware... CNET News.com
Zoho launches document sharing... Webware.com
iPhone day 42: Steve Jobs,... Valleywag


